QualityStocksNewsBreaks Archives - Page 673 of 1387

FridayApr 16, 2021 9:23 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (FSE: N29) (OTCQB: NEXCF) Releases Financial Report for Q4 2020

Nextech AR Solutions (CSE: NTAR) (NEO: NTAR) (FSE: N29) (OTCQB: NEXCF), a developer and operator of augmented reality (“AR”) platforms, has released its financial and operating results for Q4 and fiscal year ending Dec. 31, 2020. Highlights from the report include several significant financial achievements, including revenue for the period reaching $17.7 million, an increase of 342% when compared to the period ended Dec. 31, 2019. In addition, the company reported gross profit of $9.9 million, an increase of 320% compared to the period ended Dec. 31, 2019. In addition, Nextech also reported $13.6 working capital. The company’s audited financial…

ThursdayApr 15, 2021 2:12 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. at Forefront to Speed Economic Recovery

United Medical Equipment (“UME,” “UMEBSNI”) is well-positioned to help speed up economic recovery with its FDA-approved COVID-19 rapid test kits. This comes as governments in different parts of the world have expressed interest in rapid testing, citing health and economic benefits. An article on the matter reads, “New York City is wasting no time to leverage the power of this low-cost, high impact option as the city has announced the launch of its Forward Rapid-Test Program. The program will make low-cost rapid testing available to the broader public to support economic recovery by enabling businesses to more safely re-open. The…

ThursdayApr 15, 2021 1:06 pm

QualityStocksNewsBreaks – Mohawk Group Holdings Inc. (NASDAQ: MWK) Achieves Significant Growth, Including 62.3% YOY Revenue Increase

Mohawk Group (NASDAQ: MWK), a technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products, has announced significant growth on multiple fronts with the release of its Q4 and full-year 2020 results. Some of the notable highlights, documented in an article about the company, include increases in the full-year and fourth-quarter net revenue by 62.3% and 61.9%, respectively. “The full-year net revenue grew to $185.7 million from $114.5 million in the full year 2019. The fourth-quarter net revenue grew to $41.5 million from $25.6 million in the fourth quarter…

ThursdayApr 15, 2021 12:34 pm

QualityStocksNewsBreaks – Emaginos Engages InvestorBrandNetwork for Corporate Communications Expertise

Emaginos Inc., a company dedicated to improving K-12 public schools, today announced that it has selected the corporate communications expertise of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Emaginos is focused on improving the U.S. K-12 public education system through a commitment to integrated, proven best practices. Opposed to replacing public schools with charter schools, Emaginos believes in restoring neighborhood schools as focal points of their communities, providing them with a wealth of first-to-market resources from technology infrastructure to curriculum training. As part of the client partner relationship and to generate greater awareness…

ThursdayApr 15, 2021 12:09 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Shareholder Letter Outlines Program Highlights, Provides Business Update

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has shared a letter to shareholders from chair, president and CEO James Sapirstein. The letter noted that AZRX is on track to launch its niclosamide programs in the clinic, noting that just this month the company announced the initiation of RESERVOIR, its Phase 2 clinical trial of niclosamide for the treatment of COVID-19-related gastrointestinal infections; the company also established an agreement with PPD Inc. (“PPD”), a leading clinical research organization, to manage the upcoming Phase 1b/2a ICI-AC trial, planned for Q2…

ThursdayApr 15, 2021 11:38 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) ‘Covid-ID Lab’ Combines Speed of Rapid Screening with Accuracy of PCR Diagnostic

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, is set to launch a solution for improving detection of the virus responsible for the worldwide pandemic. The company recently announced European regulatory approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system. Known as “Covid-ID Lab,” the system is a commercial in-vitro diagnostic device (CE-IVD) designed to help industry professionals and government agencies screen for the virus. XPhyto’s exclusive German diagnostics partner, 3a-diagnostics GmbH, developed Covid-ID Lab to provide rapid, accurate and portable testing capabilities, granting it marketability as a product with increased convenience and decreased operating costs.…

ThursdayApr 15, 2021 11:35 am

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) to Add Reality TV Viewership Through Strategic Partnership

The Movie Studio (OTC: MVES), a vertically integrated motion picture production and distribution company with completed motion picture and production assets, today announced its entry into a strategic partnership agreement with Dining Divas LLC (www.DiningDivas.tv), which will add reality TV to its viewership for added entertainment. The partnership aligns the mutually beneficial assets and associations of the two companies with the collaboration specifically focusing on cross advertising. “We are extremely excited about the strategic partnership with the Dining Divas and the symbiotic approach that we both see regarding our respective OTT platforms, which synchronize well with their locations’ ability to…

ThursdayApr 15, 2021 11:22 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Delivering Readily-Available Solution Amid Growing Need

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, is fulfilling a growing need for improved neurological monitoring that is cost efficient, disposable and portable. When combating a highly contagious disease, disposable technology helps to ensure that the virus is not spread through equipment. Brain Scientific’s disposable EEG caps are designed for single use and also assist in shortening person-to-person contact due to ease of placement, decreasing transmission between staff and patient. “As health-care facilities and frontline workers move quickly to address COVID symptoms and provide effective treatment, disposable devices offer a solution to rapidly…

ThursdayApr 15, 2021 11:15 am

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Retains Patent Attorney to Solidify Cannabis Intellectual Property Rights

Hero Technologies (OTC: HENC), a cannabis company focused on a vertically integrated strategy, today announced that it has retained a patent attorney to help protect and monetize the intellectual property of its subsidiary, BlackBox Systems and Technologies LLC. BlackBox has developed a proprietary cannabis growing system based on aeroponic cultivation technology. The system creates ideal cannabis growing conditions, which enhance photosynthesis, produce large plant flowers and optimize harvests. The company's new intellectual property attorney is Alan M. Weisberg, Esq., a partner of Christopher & Weisberg, P.A. Weisberg is a registered patent attorney with a "preeminent" peer rating and more than…

ThursdayApr 15, 2021 11:11 am

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Targets $400M Slice of Massive Global Endoscopy Market

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has hailed its first product, the i/Blue(TM) Imaging System, as a breakthrough technology that will advance the accuracy and efficiency of bladder cancer detection and removal, thus helping it capture some market share. The global endoscopy market is valued at $46 billion, of which Imagin is positioned to target $400 million with its bladder cancer detection product. An article detailing this reads, “The company’s patented ultrasensitive imaging product based on optics and light sensors, has potential early-stage cancer-detection abilities. The company’s first target for treatment is bladder cancer.” According to…

Site Search

Company Search

Category: QualityStocksNewsBreaks